Overactive Bladder
498
30
36
311
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
127 trials with published results (26%)
Research Maturity
311 completed trials (62% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
9.4%
47 terminated out of 498 trials
86.9%
+0.3% vs benchmark
29%
144 trials in Phase 3/4
41%
127 of 311 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 311 completed trials
Clinical Trials (498)
Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead
Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease
SGLT-2 Inhibitors and Lower Urinary Tract Symptoms
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder
Comparative Efficacy and Safety if Intravesical Botulinum Toxin A Versus Platelet-Rich Plasma in the Management of Refractory Overactive Bladder : A 2 Year Study
Self-Start Triage Model for Post-Botox® Lower Urinary Tract Symptoms
Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy
Defining the Safety and Efficacy of POSterIor Tibial NeRve StimulatiON in Children
Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
Add-On ZIDA Sock Therapy for Overactive Bladder
Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet
Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
The Efficacy of Transcutaneous Tibial Nerve Stimulation in Women With Idiopathic Overactive Bladder
rTMS in Overactive Bladder
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder
TReating Incontinence for Underlying Mental and Physical Health